A new University of Utah Health study raises questions about potential muscle effects linked to the GLP-1 drugs, including decreased strength in some muscles despite minimal size loss
As of March 2, 2026, there are 54 eye side effects lawsuits in the consolidated MDL involving Mounjaro and other GLP-1 drugs
Executive Summary Glucagon-like peptide-1 (GLP-1) receptor agonists a class of diabetes and weight-loss drugs including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have seen explosive demand and unprecedented market growth in the past 23 years
A group of drugs known as amylin receptor agonists are currently advancing through clinical trials for obesity management
doi:10.1016/j.ijporl.2012.11.037
MIneral Boost B12 BOOST Super Molecule | Increase your Energy and Metabolism The B12 Boost is a vitamin and nutrient IM injection formula for those of us who continue to feel fatigued and exhausted after already filling ourselves up with coffee